CANADA – UPS has announced plans to acquire Canada’s Andlauer Healthcare Group (AHG) for US$ 1.6 billion, aiming to bolster its healthcare logistics capabilities. The acquisition, expected to close in the second half of 2025, will enhance UPS’s cold chain services, crucial for transporting temperature-sensitive medical products. AHG operates nine distribution centers and 22 […]
KENYA – The Pharmacy and Poisons Board (PPB) of Kenya has issued a critical alert, recalling multiple batches of commonly used medications due to quality concerns and potential health risks. Paracetamol injections exhibiting discoloration Three batches of paracetamol 1000mg/100ml injections have been identified as substandard, showing signs of discoloration that may indicate compromised quality. […]
UK – Tempus AI, AstraZeneca, and Pathos AI have joined forces in a US$ 200 million partnership to build an advanced artificial intelligence (AI) model for oncology. The initiative centers on creating a multimodal deep learning framework capable of analyzing diverse data types to uncover new insights into cancer biology, identify novel drug targets, and […]
SWITZERLAND – Swiss pharma giant Roche is doubling down on autoimmune disease research through a major partnership with Repertoire Immune Medicines. The collaboration, announced Wednesday, is worth up to US$ 765 million and centers on developing next-generation T cell-targeted therapies. Repertoire will receive US$ 35 million upfront from Roche’s Genentech unit, with the potential for […]
USA – Grove Biopharma, a Chicago-based biotech startup, has raised US$ 30 million in Series A funding to propel its innovative ‘Bionic Biologics’ platform aimed at tackling hard-to-treat diseases like castrate-resistant prostate cancer (CRPC). The round was led by DCVC Bio, with major backing from pharma giant Eli Lilly and other investors like InVivium Capital, […]
USA – Insilico Medicine, a clinical-stage biotech company, announced that its lead drug candidate for idiopathic pulmonary fibrosis (IPF) now has an official generic name: Rentosertib. The name was granted by the United States Adopted Names (USAN) Council, marking a symbolic step forward for a drug discovered entirely through artificial intelligence. Rentosertib is the first […]
USA – Atomwise, a company at the forefront of using AI and machine learning to find new small-molecule drugs, has named Dr. Steve Worland as its new Chief Executive Officer and a member of the Board of Directors. This major leadership shift comes as the company continues to expand its AI-powered drug discovery platform, AtomNet. […]
UK – Healx, a biotech company using artificial intelligence (AI) to find treatments for rare diseases, has named Dr. Jonathan Milner as its new non-executive chairman. This change comes as co-founder and current chairman Dr. David Brown begins academic research at Trinity College, Cambridge. Dr. Brown will continue to serve on Healx’s board during his […]
USA – Insilico Medicine, a trailblazer in using generative AI for drug discovery, has introduced its first bipedal humanoid robot—named Supervisor—to work in its AI-powered, fully-robotic drug discovery lab. This humanoid is set to transform how laboratory work is done by learning tasks typically performed by human scientists. Developed by the Insilico Robotics team, Supervisor […]
USA – Insilico Medicine, a biotech company known for its AI-driven drug discovery, has announced a new partnership with Tenacia Biotechnology, a firm focused on treatments for nervous system disorders. This collaboration aims to develop advanced therapies for brain-related diseases by combining artificial intelligence with clinical expertise. The two companies will work together in the […]
UK – The Peninsula Imaging Network (PenRAD) in the UK has integrated Qure.ai’s artificial intelligence (AI) solution, qCT, into its chest CT scan analysis across four NHS Trusts in Devon, Cornwall, and the Isles of Scilly. This deployment marks the UK’s first commercial use of AI for chest CT scans, aiming to assist radiologists in […]
USA –University Hospitals Cleveland Medical Center (UH) has initiated a clinical trial in collaboration with Qure.ai to evaluate the effectiveness of artificial intelligence (AI) in detecting early-stage lung cancer through chest X-rays. The trial focuses on the qXR-LN, an FDA-cleared AI tool developed by Qure.ai, designed to identify potential lung nodules that may be missed […]
XRP HEALTHCARE L.L.C | License Number: 2312867.01 | Dubai | © Copyright 2025 | All Rights Reserved